Dr. Adrian Carter is an NHMRC Career Development and Senior Research Fellow and Head, Neuroethics and Public Policy Group at the School of Psychological Sciences and Monash Institute of Cognitive and Clinical Neurosciences, Monash University. He is also Director, Neuroethics Program, Australian Research Council Centre of Excellence for Integrative Brain Function and Chair, Australian Brain Alliance Neuroethics Subcommittee, Australian Academy of Science. His research examines the impact of neuroscience on our understanding and treatment of addiction and other compulsive behaviours, including: agency, identity, moral responsibility, the use of coercion and the capacity for voluntary control of addictive or compulsive behaviours; and the use of emerging technologies such as brain stimulation and neuroimaging, to treat addiction. He received the Australasian Professional Society of Alcohol and Other Drugs “Early Career Award for Excellence in Research and Science” (2012) and the Australian National Drug and Alcohol Award for Excellence in Research (2010). He has over 120 publications, including the book ‘Addiction Neuroethics: The Promises and Perils of Addiction Neuroscience’ (Cambridge University Press, 2012). Dr Carter has been an advisor to the World Health Organization, the European Monitoring Centre for Drugs and Drug Addiction, the Australian Ministerial Council on Drugs Strategy and United Nations Office on Drugs and Crime. He is also Deputy Chair of the Australian Academy of Science Early and Mid Career Research Forum Executive.
Arisa Ema is the Assistant Professor at the University of Tokyo and Visiting Researcher at RIKEN Center for Advanced Intelligence Project in Japan. She is a researcher in Science and Technology Studies (STS), and her primary interest is to investigate the benefits and risks of artificial intelligence by organizing an interdisciplinary research group. She is a co-founder of the Acceptable Intelligence with Responsibility Study Group (AIR), established in 2014, which seeks to address emerging issues and relationships between artificial intelligence and society. She is a member of the Ethics Committee of the Japanese Society for Artificial Intelligence (JSAI), which released the Japanese Society for Artificial Intelligence Society Ethical Guidelines in 2017. She is also one of the organizers of the 2017 “IEEE Ethically Aligned Design, Version 1 Workshop in Japan.” She obtained her Ph.D. from the University of Tokyo in 2012 and previously held a position as Assistant Professor at the Hakubi Center for Advanced Research, Kyoto University.
Tamami Fukushi is the Deputy Manager in the Department of Research Infrastructure at Japan’s Agency for Medical Research and Development (AMED). She is also the consultant for the Global Neuroethics Summit. She started her career in Neuroethics in 2005 at the Research Institute of Science and Technology for Society (RISTEX), Japan Science and Technology Agency (JST) after 10 years of research in neural control of movement. Her current interest is ELSI of advanced technology of neuroscience in the context of science policy and regulatory science. She recently published a book titled “Social Implementation of Nepourodegenerative Disease Research and Neuroethics” In: Wada, K., (ed.) Neurodegenerative Disorders as Systemic Diseases. Pp.295-304, Springer and “Neuroethics in Japan” In: Rommelfanger, K., (ed.) Handbooks in Neuroethics. Routledge.
Dr. Illes is the Professor of Neurology and Canada Research Chair in Neuroethics at the University of British Columbia. She is the Director of the National Core for Neuroethics at UBC, and faculty in the Centre for Brain Health at UBC and at the Vancouver Coastal Health Research Institute. She also holds affiliate appointments in the School of Population and Public Health and the School of Journalism at UBC, and in the Department of Computer Science and Engineering at the University of Washington in Seattle, WA. USA, and is a Life Member of Clare Hall, Cambridge University. Dr. Illes’ research focuses on ethical, legal, social and policy challenges specifically at the intersection of the sciences of the central nervous system and biomedical ethics. This includes empirical studies in stem cells and regenerative medicine, neurogenetics, brain injury, aging and neurodevelopmental disorders, mental health and addictions, and the commercialization of neuroscience and personalization of health. Her research results in actionable practical guidance, frameworks for empowering the ethical development and communication of science, and evidence for informed policy-making. She also leads a robust program of research and outreach devoted to improving public literacy about brain research and engaging stakeholders on a global scale.
Dr. Illes is the President of the International Neuroethics Society that she founded with others in 2006, and Vice Chair of the Standing Committee on Ethics for the Canadian Institutes of Health Research. She is a member of the Dana Alliance for Brain Initiatives and a Canadian representative to IBRO US-Canada Committee. Dr. Illes was elected to the Royal Society (Life Sciences) in 2012), to the Canadian Academy of Health Sciences in 2011, and to the American Association for the Advancement of Science (Neuroscience) in 2013. Her latest book (Oxford University Press, 2017) is Neuroethics: Anticipating the Future.
Ilina Singh is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Oxford Uehiro Centre for Practical Ethics). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families. Recent projects include the ADHD VOICES project (www.adhdvoices.com); Neuroenhancement Responsible Research and Innovation (www.nerri.eu); and the Urban Brain Project (www.urbanbrainlab.com). In 2014, Professor Singh received a Wellcome Trust Senior Investigator Award for a study entitled: Becoming Good: Early Intervention and Moral Development in Child Psychiatry.
Professor Singh has published widely in eminent journals, including Nature, Nature Reviews Neuroscience, Social Science and Medicine, and the American Journal of Bioethics. She is the lead editor of a new volume: BioPrediction, Biomarkers and Bad Behavior: Scientific, Ethical and Legal Challenges (co-edited with Walter-Sinnott Armstrong and Julian Savulescu), published by Oxford University Press. She has acted as an advisor to the Nuffield Council on Bioethics, NICE, NIMH and other organisations. She is co-editor of the journal BioSocieties and on the editorial board of the American Journal of Bioethics-Neuroscience and Qualitative Psychology.
Jialin Charles Zheng
Jialin Zheng is Dean of the Tongji University School of Medicine, where he is a Professor of Neuroscience and Regenerative Medicine. He is simultaneously a Professor of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center (UNMC). Dr. Zheng’s research focuses on the understanding and treatment of neurodegenerative disorders such as Parkinson’s Disease. Ultimately it is the mission of his lab to develop drugs that will inhibit neurotoxin production and enhance neuronal repair in the brain. Dr. Zheng has been at the fore of UNMC’s collaborative efforts in China. He is the Director of UNMC’s Asia Pacific Rim Development Program and has worked to create more than 10 partnerships in China, including the formation of the first joint U.S./Chinese M.D./Ph.D. program. Dr. Zheng received his M.D. from Xuzhou Medical College in China and served as a visiting scholar at the State University of New York at Buffalo prior to joining UNMC.